Naloxone (NARCAN®, EVZIO®) is a prescription medication that safely and effectively reverses an opioid overdose. Naloxone does not “enable” drug use, have “street” or resale value, or make a prescriber liable for a patient’s overdose. Medical providers can prescribe naloxone directly to patients, become an Overdose Response Program (ORP) to certify patients and provide naloxone through a standing order, or refer patients to a local ORP training. Newly promulgated Maryland regulations (COMAR 10.13.03) support the co-prescribing of naloxone to patients. For more information, please see the Naloxone Co-prescribing Fact Sheet.
The Maryland Department of Health (MDH) also authorizes public and private practices and organizations to become ORPs, which provide standardized training on recognizing the signs of an overdose and responding appropriately, including administering naloxone. Naloxone can also be obtained at a pharmacy without a prescription.
For more information on naloxone formulations and upcoming ORP training, and instructions on becoming an ORP, please visit NaloxoneMD.org
